National Institute On Drug Abuse To Research Ayahuasca's Active Ingredient DMT In Partnership With Psilera Inc.

Psilera Inc., a Florida-based biotech company specializing in the psychedelics sector, announced a “research and development agreement” with the National Institute on Drug Abuse (NIDA) for the launch of a series of preclinical studies on Psilera’s psychedelic drug pipeline.

The pipeline includes an intranasal formulation of N,N-dimethyltryptamine (DMT), the active ingredient in ayahuasca, a ceremonial hallucinogenic drink from the Amazon basin.

The company recently closed $2.5 million in funding for research, scientific and clinical personnel hiring and general working purposes.

NIDA is a federal …

Full story available on Benzinga.com

More National Institute On Drug Abuse To Research Ayahuasca's Active Ingredient DMT In Partnership With Psilera Inc.